Australia's Cann Global rises on positive sales momentum

Cann Global

31/05/2022 04:31

** Shares of medical cannabis co Cann Global  CGB.AX  rise
as much as 3.7% to A$0.028, though stock value down 7.1% this
month
    ** Co sees good momentum in interest driving early sales in
its new product range across all three divisions  urn:newsml:reuters.com:*:nASX7t2bb2
    ** Says co expects the Grass Roots range of products to
generate increased sales for the first quarter of FY23 
    ** Stock down 56.8% this year, as of last close, vs a 2.7%
decrease in the benchmark S&P/ASx 200 index  .AXJO  


 (Reporting by Roushni Nair in Bengaluru)
 ((Roushni.Nair@thomsonreuters.com;))